RedHill Biopharma (Israel) Profile

ILS 3.9  2.04%

RedHill Biopharma Summary

RedHill Biopharma Ltd (RDHL) is traded on Tel Aviv Stock Exchange in Israel. It is located in 21 Ha'arba'a Street and employs 74 people. The company currently falls under 'Small-Cap' category with current market capitalization of 422.82 M. RedHill Biopharma Ltd has 213.44 M outstanding shares. REDHILL BIOPHARMA has accumulated about 46.2 M in cash with (44.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22.
Check RedHill Biopharma Probability Of Bankruptcy

RedHill Biopharma Risk Profiles

Key Fundamentals

RedHill Biopharma Against Markets

Current Ratings

RedHill Biopharma 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 31% 
Equity ratings for RedHill Biopharma Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on the development and commercialization of late clinical-stage, proprietary, and in-licensedacquired drugs for the treatment of gastrointestinal and inflammatory diseases, and cancer. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma is traded on Tel Aviv Stock Exchange in Israel. more
NameRedHill Biopharma Ltd
CEOOri ShiloView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business Address21 Ha'arba'a Street
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
Contact Number972 3 541 3131
CurrencyILS - Israeli Shekel

Diversify with RedHill Biopharma Ltd

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add RedHill Biopharma Ltd to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


RedHill Biopharma Corporate Directors
Ofer Tsimchi Director
Shmuel Cabilly Director
Kenneth Reed Director, Ph.D